Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  InflammoPharmacology

• Publication date

  2016-01-09

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s10787-015-0259-7PMID 26749133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Nuclear Factor-ĸB in Breast and Colorectal Cancer

  2013cited by this paper
• A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer

  2013cited by this paper
• The Multifaceted Effects of Omega-3 Polyunsaturated Fatty Acids on the Hallmarks of Cancer

  2013cited by this paper
• Molecular Diagnostics

  2013cited by this paper
• NF-κB in colorectal cancer

  2013cited by this paper
• Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line

  2013cited by this paper
• Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis

  2013cited by this paper
• Role of cytokines in experimentally induced lung cancer and chemoprevention by COX-2 selective inhibitor, etoricoxib

  2012cited by this paper
• Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo

  2012cited by this paper
• Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype

  2012cited by this paper
• Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy.

  2012cited by this paper
• Role of interleukin-10 in breast cancer

  2012cited by this paper
• Ras Signaling Pathway in the Chemopreventive Action of Different Ratios of Fish Oil and Corn Oil in Experimentally Induced Colon Carcinogenesis

  2012cited by this paper
• Interleukin-10

  2012cited by this paper
• Evaluation of the role of oxidative stress in chemopreventive action of fish oil and celecoxib in the initiation phase of 7,12-dimethyl benz(α)anthracene-induced mammary carcinogenesis

  2011cited by this paper
• Chemopreventive effects of NSAIDs on cytokines and transcription factors during the early stages of colorectal cancer

  2011cited by this paper
• PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells

  2011cited by this paper
• A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study

  2011cited by this paper
• The Two Faces of Interferon-γ in Cancer

  2011cited by this paper
• NF-κB and cancer: how intimate is this relationship

  2010cited by this paper
• Anti-cancer effects of celecoxib on nasopharyngeal carcinoma HNE-1 cells expressing COX-2 oncoprotein

  2010cited by this paper
• [Celecoxib promotes apoptosis of breast cancer cell line MDA-MB-231 through down-regulation of the NF-kappaB pathway].

  2009cited by this paper
• Mechanism of action of celecoxib on normal and acid-challenged gastric mucosa.

  2009cited by this paper
• Effect of Fish Oil Supplementation for Two Generations on Changes of Lymphocyte Function Induced by Walker 256 Cancer Cachexia in Rats

  2009cited by this paper
• Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1

  2009cited by this paper
• Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats.

  2008cited by this paper
• Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis.

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4

  2008cited by this paper
• Yin and yang interplay of IFN-γ in inflammation and autoimmune disease

  2007cited by this paper
• Role of oxidative stress in lansoprazole-mediated gastric and hepatic protection in Wistar rats.

  2007cited by this paper
• Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

  2007cited by this paper
• Yin and yang interplay of IFN-gamma in inflammation and autoimmune disease.

  2007cited by this paper
• Oestrogen receptor negative breast cancers exhibit high cytokine content

  2007cited by this paper
• The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth?

  2007cited by this paper
• Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.

  2006cited by this paper
• Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell‐cycle arrest, caspase‐3 activation, and downregulation of Cox‐2 expression and are synergistic with hydroxyurea or imatinib

  2006cited by this paper
• Effect of Altering Dietary ω-6/ω-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2

  2006cited by this paper
• Cardiovascular Risks of Cyclooxygenase-2 Inhibitors: Where We Stand Now

  2005cited by this paper
• Role of nuclear factor-κ B in melanoma

  2005cited by this paper
• Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions

  2005cited by this paper
• Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.

  2005cited by this paper
• Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells

  2005cited by this paper
• Role of nuclear factor-kappa B in melanoma.

  2005cited by this paper
• Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).

  2005cited by this paper
• 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide.

  2004cited by this paper
• Induction of a CD4+ T Regulatory Type 1 Response by Cyclooxygenase-2-Overexpressing Glioma1

  2004cited by this paper
• Ammonium Trichloro(dioxoethylene-o,o′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop

  2004cited by this paper
• Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.

  2004cited by this paper
• IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins1

  2004cited by this paper
• Tumor-host immune interactions and dendritic cell dysfunction.

  2004cited by this paper
• Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.

  2004cited by this paper
• Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma.

  2004cited by this paper
• NF-kappaB binds to a polymorphic repressor element in the MMP-3 promoter.

  2004cited by this paper
• COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

  2004cited by this paper
• Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates TNF-Induced NF-κB Activation through Inhibition of Activation of IκBα Kinase and Akt in Human Non-Small Cell Lung Carcinoma: Correlation with Suppression of COX-2 Synthesis1

  2004cited by this paper
• Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?

  2003cited by this paper
• Immune restoration in head and neck cancer patients via cyclooxygenase inhibition: an update.

  2003cited by this paper
• Mutational analysis of IkappaBalpha in hematologic malignancies.

  2003cited by this paper
• Mutational analysis of IκBα in hematologic malignancies

  2003cited by this paper
• Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-κB and IκB kinase-α in human colorectal cancer epithelial cells

  2003cited by this paper
• COX‐2 inhibits Fas‐mediated apoptosis in cholangiocarcinoma cells

  2002cited by this paper
• Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids.

  2002cited by this paper
• Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.

  2002cited by this paper
• Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB

  2001cited by this paper
• Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

  2001cited by this paper
• Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.

  2001cited by this paper
• Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.

  2001cited by this paper
• Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.

  2001cited by this paper
• Comparison of Serum Interleukin-10 (IL-10) Levels Between Normal Volunteers and Patients with Advanced Melanoma

  2001cited by this paper
• Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2

  2001cited by this paper
• Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer

  2001cited by this paper
• Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels

  2000cited by this paper
• Vitamin C Inhibits NF-κB Activation by TNF Via the Activation of p38 Mitogen-Activated Protein Kinase1

  2000cited by this paper
• Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma.

  2000cited by this paper
• Molecular pathology of cyclooxygenase-2 in neoplasia.

  2000cited by this paper
• Interleukin-4 and breast cancer

  2000cited by this paper
• Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis1

  2000cited by this paper
• Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

  2000cited by this paper
• Over‐expression of cyclooxygenase‐2 in human prostate adenocarcinoma

  2000cited by this paper
• Cyclooxygenases: structural, cellular, and molecular biology.

  2000cited by this paper
• Biochemical effects of a diet containing foods enriched with n-3 fatty acids.

  2000cited by this paper
• Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.

  2000cited by this paper
• Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells.

  1999cited by this paper
• Aberrant rel/nfkb genes and activity in human cancer

  1999cited by this paper
• Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

  1998cited by this paper
• Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB

  1998cited by this paper
• Effect of dexamethasone on interleukin‐1β‐(IL‐1β)‐induced nuclear factor‐κB (NF‐κB) and κB‐dependent transcription in epithelial cells

  1998cited by this paper
• The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase 1 and 2 and levels of p21ras in rat mammary glands.

  1998cited by this paper
• Increased expression of cyclooxygenase-2 to -1 in human colorectal cancers and adenomas, but not in hyperplastic polyps.

  1998cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

  1998cited by this paper
• Regulation of Immune Responses by NF-κB/Rel Transcription Factors

  1998cited by this paper
• Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells.

  1998cited by this paper
• Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells*

  1997cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Structure, regulation and function of NF-kappa B.

  1994cited by this paper
• Interleukin-10.

  1993cited by this paper
• Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression

  1992cited by this paper
• Omega-3 fatty acids in health and disease and in growth and development.

  1991cited by this paper
• Identification of a T cell-derived b cell growth factor distinct from interleukin 2

  1982cited by this paper

• Contribution of non-steroidal anti-inflammatory drugs to breast cancer treatment: In vitro and in vivo studies

  2024cites this paper
• Modulation of inflammatory mediators involved in the antinociceptive and anti-inflammatory effects of a new thioamide derivative: thiocyanoacetamide

  2023cites this paper
• Current views on in vivo models for breast cancer research and related drug development

  2023cites this paper
• New-Generation Probiotics

  2019cites this paper
• Differential ratios of fish/corn oil ameliorated the colon carcinoma in rat by altering intestinal intraepithelial CD8+ T lymphocytes, dendritic cells population and modulating the intracellular cytokines.

  2018cites this paper
• Conjugated linoleic acid enriched skim milk prepared with Lactobacillus fermentum DDHI27 endorsed antiobesity in mice.

  2018cites this paper
• A Comparison of the Anti-Inflammatory Effects of Cis-9, Trans-11 Conjugated Linoleic Acid to Celecoxib in the Collagen-Induced Arthritis Model

  2017cites this paper
• Carcinogenesis in rats subjected to a new model ureterosigmoidostomy and treated with L-lysine.

  2016cites this paper